Johnson & Johnson JNJ
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NYSE · United States · jnj.com
Johnson & Johnson is a global healthcare company headquartered in New Brunswick, New Jersey, focused on pharmaceutical products and medical devices following the 2023 spin-off of its consumer health division as Kenvue. The company develops, manufactures, and markets innovative medicines and medical technologies across oncology, immunology, neuroscience, cardiovascular, and infectious disease therapeutic areas. Johnson & Johnson is one of the world's largest and most valuable healthcare companies.
Key ratios
CashFromOperationsYoYGrowth TTM -0.08
CashFromOperationsYoYGrowth 2025 0.01
CashFromOperationsYoYGrowth 2024 0.06
CashFromOperationsYoYGrowth 2023 0.08
DilutedEPSYoYGrowth TTM -0.04
DilutedEPSYoYGrowth 2025 0.91
DilutedEPSYoYGrowth 2024 0.11
DilutedEPSYoYGrowth 2023 -0.15
FreeCashFlowOnSale TTM 0.18
FreeCashFlowOnSale 2025 0.21
FreeCashFlowOnSale 2024 0.22
FreeCashFlowOnSale 2023 0.22
NetIncomeMargin TTM 0.22
NetIncomeMargin 2025 0.28
NetIncomeMargin 2024 0.16
NetIncomeMargin 2023 0.41
ReturnOnAssets TTM 0.08
ReturnOnAssets 2025 0.09
ReturnOnAssets 2024 0.08
ReturnOnAssets 2023 0.08
ReturnOnEquity TTM 0.26
ReturnOnEquity 2025 0.35
ReturnOnEquity 2024 0.2
ReturnOnEquity 2023 0.18
TotalRevenueYoYGrowth TTM 0.08
TotalRevenueYoYGrowth 2025 0.06
TotalRevenueYoYGrowth 2024 0.04
TotalRevenueYoYGrowth 2023 0.06
Recent news
Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida
2026-06-15 · Johnson & Johnson Investor Relations
J&J multiple myeloma drug gains edge in earlier stage disease
2026-06-15 · BioPharma Dive